Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Compositions and methods of using nintedanib for treating ocular diseases with abnormal neovascularization

Compositions and methods of using nintedanib for treating ocular diseases with abnormal neovascularization

US Patent 11246864 · Granted Feb 15, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compositions and methods of using nintedanib for treating ocular diseases with a2025
Topical ophthalmological compositions2025
Anti-angiogenic antibody-drug conjugates2025
Anti-angiogenic antibody-drug conjugates2025
Compositions and methods for treating pterygium recurrence2025
Composition for treating ocular hyperemia and a method for treating ocular hyper2024
Composition for treating ocular hyperemia and a method for treating ocular hyper2024
Topical ophthalmological compositions2024
Topical ophthalmological compositions2024
Compositions with permeation enhancers for drug delivery2024
Compositions and methods of using nintedanib for treating ocular diseases with a2024
Compositions and methods of using nintedanib for treating ocular diseases with a2024